Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 29, 2025 07:25 ET | Source: Dyadic International, Inc.

Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025

Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025
October 06, 2025 08:30 ET | Source: Dyadic International, Inc.

Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments

Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments
September 04, 2025 09:00 ET | Source: Dyadic International, Inc.

Dyadic to Present at Investor Conferences and BPI East

JUPITER, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc., d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology...
August 13, 2025 16:01 ET | Source: Dyadic International, Inc.

Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

Completed Strategic Leadership and Operational Transformation from R&D to Commercial OperationsRebranded as Dyadic Applied BioSolutions to Reflect Our New Operational PrioritiesFull Redesign of...
August 05, 2025 16:11 ET | Source: Dyadic International, Inc.

Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

JUPITER, Fla., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable...
July 31, 2025 08:47 ET | Source: Dyadic International, Inc.

UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

JUPITER, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of...
July 30, 2025 16:02 ET | Source: Dyadic International, Inc.

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock
June 02, 2025 08:35 ET | Source: Dyadic International, Inc.

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

Rapid commercial validation has been achieved through key partnerships disrupting high value/high growth marketsLeadership team realigned in order to enable execution of ancillary protein...
May 14, 2025 16:05 ET | Source: Dyadic International, Inc.

Dyadic Reports First Quarter 2025 Financial Results and Highlights of Recent Company Progress

Expanded life science and industrial portfolio with six additional life science products in developmentAdvances toward commercialization of functional recombinant solutions for cell culture media,...
May 01, 2025 15:00 ET | Source: Dyadic International, Inc.

Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

JUPITER, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a biotechnology company focused on the efficient...